首页 > 最新文献

mSphere最新文献

英文 中文
Antibiotic susceptibility of Escherichia coli is affected by evolutionary history but not by history of elemental limitation. 大肠杆菌的抗生素敏感性受进化历史的影响,而不受元素限制史的影响。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-23 DOI: 10.1128/msphere.00538-25
Marissa A Donofrio, Heather L Blasius, Catherine C Nguyen, Alexa L Schnell, Caroline B Turner

Antibiotic resistance in bacteria is a global public health threat. To understand how the evolution of antibiotic susceptibility is affected by environmental conditions and prior evolutionary history, we worked with populations from the Long-Term Evolution Experiment (LTEE) with Escherichia coli. These populations previously evolved independently for 50,000 generations in an environment without antibiotics, making them an ideal system for studying the effect of evolutionary history on adaptation to new selective pressures. We further evolved five of the LTEE populations, as well as their shared ancestor, under either carbon- or nitrogen-limited conditions and then tested intrinsic resistance to four antibiotics. Evolution under elemental limitation did not have a significant impact on resistance to any of the tested antibiotics. However, some LTEE populations did have higher resistance than other populations. Susceptibility also varied within one population, which had the lowest level of resistance to all four antibiotics. We hypothesized that resistance levels might differ between two clades of bacteria that have coexisted within this population for more than 40,000 generations. Interestingly, although antibiotic susceptibility varied within the population, there was no consistent difference between clades. Instead, one particular clone isolated from the population exhibited higher resistance than the other clones sampled. These findings indicate that antibiotic resistance can vary both within and between experimentally evolved populations, even in the absence of direct selection on resistance. Our results also show that measured levels of susceptibility may depend on stochastic sampling effects during isolation of clones.IMPORTANCEAntibiotic resistance is one of the most pressing health challenges worldwide, and understanding how bacteria evolve resistance, even when not directly exposed to antibiotics, is critical for managing and predicting emerging threats. Our study leverages the unique Long-Term Evolution Experiment with Escherichia coli to show that both the evolutionary history of bacterial populations and random variation among individual clones can significantly influence intrinsic antibiotic susceptibility. Our results also suggest that elemental limitation, while a critical environmental variable, may not be an important driver of intrinsic antibiotic susceptibility, at least over short time frames.

细菌的抗生素耐药性是一个全球性的公共卫生威胁。为了了解抗生素敏感性的进化如何受到环境条件和先前进化史的影响,我们研究了大肠杆菌长期进化实验(LTEE)的种群。这些种群以前在没有抗生素的环境中独立进化了5万代,使它们成为研究进化史对适应新选择压力的影响的理想系统。我们在碳或氮限制的条件下进一步进化了五个LTEE种群,以及它们的共同祖先,然后测试了对四种抗生素的内在耐药性。在元素限制下的进化对任何被测抗生素的耐药性没有显著影响。然而,一些LTEE人群确实比其他人群具有更高的耐药性。在一个人群中,对所有四种抗生素的耐药性水平最低,易感性也有所不同。我们假设,在这个种群中共存了4万多代的两个细菌分支之间,抗性水平可能存在差异。有趣的是,虽然抗生素敏感性在人群中有所不同,但在进化支之间没有一致的差异。相反,从种群中分离出的一个特定克隆比其他克隆表现出更高的抗性。这些发现表明,即使在没有直接选择耐药性的情况下,抗生素耐药性在实验进化的种群内部和种群之间也会发生变化。我们的结果还表明,测量的敏感性水平可能取决于克隆分离期间的随机抽样效应。抗生素耐药性是世界范围内最紧迫的健康挑战之一,了解细菌如何进化出耐药性,即使没有直接接触抗生素,对于管理和预测新出现的威胁至关重要。我们的研究利用独特的大肠杆菌长期进化实验,表明细菌群体的进化史和个体克隆之间的随机变异都可以显著影响内在的抗生素敏感性。我们的研究结果还表明,元素限制虽然是一个关键的环境变量,但可能不是内在抗生素敏感性的重要驱动因素,至少在短时间内是这样。
{"title":"Antibiotic susceptibility of <i>Escherichia coli</i> is affected by evolutionary history but not by history of elemental limitation.","authors":"Marissa A Donofrio, Heather L Blasius, Catherine C Nguyen, Alexa L Schnell, Caroline B Turner","doi":"10.1128/msphere.00538-25","DOIUrl":"https://doi.org/10.1128/msphere.00538-25","url":null,"abstract":"<p><p>Antibiotic resistance in bacteria is a global public health threat. To understand how the evolution of antibiotic susceptibility is affected by environmental conditions and prior evolutionary history, we worked with populations from the Long-Term Evolution Experiment (LTEE) with <i>Escherichia coli</i>. These populations previously evolved independently for 50,000 generations in an environment without antibiotics, making them an ideal system for studying the effect of evolutionary history on adaptation to new selective pressures. We further evolved five of the LTEE populations, as well as their shared ancestor, under either carbon- or nitrogen-limited conditions and then tested intrinsic resistance to four antibiotics. Evolution under elemental limitation did not have a significant impact on resistance to any of the tested antibiotics. However, some LTEE populations did have higher resistance than other populations. Susceptibility also varied within one population, which had the lowest level of resistance to all four antibiotics. We hypothesized that resistance levels might differ between two clades of bacteria that have coexisted within this population for more than 40,000 generations. Interestingly, although antibiotic susceptibility varied within the population, there was no consistent difference between clades. Instead, one particular clone isolated from the population exhibited higher resistance than the other clones sampled. These findings indicate that antibiotic resistance can vary both within and between experimentally evolved populations, even in the absence of direct selection on resistance. Our results also show that measured levels of susceptibility may depend on stochastic sampling effects during isolation of clones.IMPORTANCEAntibiotic resistance is one of the most pressing health challenges worldwide, and understanding how bacteria evolve resistance, even when not directly exposed to antibiotics, is critical for managing and predicting emerging threats. Our study leverages the unique Long-Term Evolution Experiment with <i>Escherichia coli</i> to show that both the evolutionary history of bacterial populations and random variation among individual clones can significantly influence intrinsic antibiotic susceptibility. Our results also suggest that elemental limitation, while a critical environmental variable, may not be an important driver of intrinsic antibiotic susceptibility, at least over short time frames.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0053825"},"PeriodicalIF":3.1,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147499665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Within-patient evolution of Pseudomonas aeruginosa populations during antimicrobial treatment. 铜绿假单胞菌群体在抗菌治疗期间的患者内进化。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-16 DOI: 10.1128/msphere.00656-25
Giuseppe Fleres, Ellen G Kline, Kevin M Squires, Tyler Tate, Hannah M Creager, Ryan K Shields, Daria Van Tyne
<p><p>Multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i> infections pose a major challenge to effective treatment. Understanding genomic adaptations during antimicrobial therapy in patients infected with this pathogen is crucial for preventing therapeutic failure. Here, we investigated the population diversity and evolution of <i>P. aeruginosa</i> collected longitudinally from six patients who evolved multidrug-resistant infections. Serial clinical <i>P. aeruginosa</i> single-colony isolates (<i>n</i> = 63) and culture-enriched metagenomic population samples (<i>n</i> = 39) were collected and subjected to whole-genome sequencing. The resulting data were used to characterize and compare the species composition, multi-locus sequence types (STs), and resistance-associated mutations present within each sample type. Single-colony isolate sequencing showed that each patient was infected with a single <i>P. aeruginosa</i> strain that accumulated mutations and became increasingly more antibiotic-resistant over time. Mutations in genes associated with β-lactam resistance, including <i>ampC, ftsI</i>, and <i>mexR,</i> arose over time and corresponded with changes in antimicrobial susceptibility in single-colony isolates. Species profiling of culture-enriched metagenomic populations revealed that all samples contained <i>P. aeruginosa</i>, but also additional gram-negative pathogens. Metagenomic analysis of culture-enriched populations identified resistance-associated mutations at low frequency, many of which were not identified in single-colony isolates from the same sample. In some cases, resistance-associated mutations initially detected at low frequency rose to fixation after antimicrobial treatment. Overall, this study shows that population-based metagenomic sequencing effectively captures the within-patient genomic diversity of <i>P. aeruginosa</i> during antimicrobial therapy and could aid the detection and interpretation of resistance-associated mutations in this pathogen.</p><p><strong>Importance: </strong><i>Pseudomonas aeruginosa</i> infections are notoriously difficult to treat and are associated with high rates of morbidity and mortality. While the genetic basis of resistance in <i>P. aeruginosa</i> is well documented <i>in vitro</i>, less is known about how resistance evolves within patients during antibiotic therapy. Standard approaches based on analysis of clonal isolates may miss within-patient diversity, potentially overlooking low-frequency mutations that contribute to treatment failure. In this study, we compared single-colony isolate whole-genome sequencing with culture-enriched metagenomic sequencing to monitor the evolution of <i>P. aeruginosa</i> populations in patients receiving antibiotic therapy. The culture-enriched metagenomic approach enabled the detection of emerging resistance mutations, such as low-frequency variants in <i>ampC</i> and <i>ftsI</i>, before these variants rose to fixation. It also revealed genetically res
多药耐药(MDR)铜绿假单胞菌感染是有效治疗的主要挑战。了解感染这种病原体的患者在抗微生物治疗期间的基因组适应对于预防治疗失败至关重要。在这里,我们研究了铜绿假单胞菌的种群多样性和进化,从6例进化为多药耐药感染的患者纵向收集。收集临床系列铜绿假单菌落分离物(n = 63)和培养富集的宏基因组群体样本(n = 39)并进行全基因组测序。结果数据用于表征和比较每种样品类型中存在的物种组成、多位点序列类型(STs)和抗性相关突变。单菌落分离测序显示,每位患者都感染了单一的铜绿假单胞菌菌株,该菌株积累了突变,并随着时间的推移变得越来越耐抗生素。与β-内酰胺耐药性相关的基因突变,包括ampC、ftsI和mexR,随着时间的推移而出现,并与单菌落分离物的抗菌敏感性变化相对应。培养富集的宏基因组种群的物种分析显示,所有样本都含有铜绿假单胞菌,但也含有额外的革兰氏阴性病原体。对培养富集群体的宏基因组分析发现了低频率的耐药性相关突变,其中许多突变在同一样本的单菌落分离株中未被发现。在某些情况下,最初以低频率检测到的耐药性相关突变在抗菌药物治疗后上升到固定。总体而言,本研究表明,基于群体的宏基因组测序可以有效地捕获抗微生物治疗期间铜绿假单胞菌患者体内的基因组多样性,并有助于检测和解释该病原体的耐药性相关突变。重要性:铜绿假单胞菌感染是众所周知的难以治疗,并与高发病率和死亡率相关。虽然铜绿假单胞菌耐药的遗传基础在体外得到了很好的记录,但对抗生素治疗期间患者体内的耐药如何演变知之甚少。基于克隆分离株分析的标准方法可能会错过患者内部的多样性,潜在地忽略了导致治疗失败的低频突变。在这项研究中,我们比较了单菌落分离的全基因组测序和培养富集的宏基因组测序,以监测铜绿假单胞菌群体在接受抗生素治疗的患者中的进化。培养富集的宏基因组方法能够在ampC和ftsI变异体固定之前检测到新出现的耐药突变,如ampC和ftsI的低频变异体。它还揭示了单独分离测序所遗漏的遗传抗性亚群。总的来说,我们的研究结果强调了基于人群的宏基因组测序在捕获感染期间细菌适应方面的价值,并强调了其改善耐药性监测和指导个性化抗菌药物治疗的潜力。
{"title":"Within-patient evolution of <i>Pseudomonas aeruginosa</i> populations during antimicrobial treatment.","authors":"Giuseppe Fleres, Ellen G Kline, Kevin M Squires, Tyler Tate, Hannah M Creager, Ryan K Shields, Daria Van Tyne","doi":"10.1128/msphere.00656-25","DOIUrl":"https://doi.org/10.1128/msphere.00656-25","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Multidrug-resistant (MDR) &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; infections pose a major challenge to effective treatment. Understanding genomic adaptations during antimicrobial therapy in patients infected with this pathogen is crucial for preventing therapeutic failure. Here, we investigated the population diversity and evolution of &lt;i&gt;P. aeruginosa&lt;/i&gt; collected longitudinally from six patients who evolved multidrug-resistant infections. Serial clinical &lt;i&gt;P. aeruginosa&lt;/i&gt; single-colony isolates (&lt;i&gt;n&lt;/i&gt; = 63) and culture-enriched metagenomic population samples (&lt;i&gt;n&lt;/i&gt; = 39) were collected and subjected to whole-genome sequencing. The resulting data were used to characterize and compare the species composition, multi-locus sequence types (STs), and resistance-associated mutations present within each sample type. Single-colony isolate sequencing showed that each patient was infected with a single &lt;i&gt;P. aeruginosa&lt;/i&gt; strain that accumulated mutations and became increasingly more antibiotic-resistant over time. Mutations in genes associated with β-lactam resistance, including &lt;i&gt;ampC, ftsI&lt;/i&gt;, and &lt;i&gt;mexR,&lt;/i&gt; arose over time and corresponded with changes in antimicrobial susceptibility in single-colony isolates. Species profiling of culture-enriched metagenomic populations revealed that all samples contained &lt;i&gt;P. aeruginosa&lt;/i&gt;, but also additional gram-negative pathogens. Metagenomic analysis of culture-enriched populations identified resistance-associated mutations at low frequency, many of which were not identified in single-colony isolates from the same sample. In some cases, resistance-associated mutations initially detected at low frequency rose to fixation after antimicrobial treatment. Overall, this study shows that population-based metagenomic sequencing effectively captures the within-patient genomic diversity of &lt;i&gt;P. aeruginosa&lt;/i&gt; during antimicrobial therapy and could aid the detection and interpretation of resistance-associated mutations in this pathogen.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;&lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; infections are notoriously difficult to treat and are associated with high rates of morbidity and mortality. While the genetic basis of resistance in &lt;i&gt;P. aeruginosa&lt;/i&gt; is well documented &lt;i&gt;in vitro&lt;/i&gt;, less is known about how resistance evolves within patients during antibiotic therapy. Standard approaches based on analysis of clonal isolates may miss within-patient diversity, potentially overlooking low-frequency mutations that contribute to treatment failure. In this study, we compared single-colony isolate whole-genome sequencing with culture-enriched metagenomic sequencing to monitor the evolution of &lt;i&gt;P. aeruginosa&lt;/i&gt; populations in patients receiving antibiotic therapy. The culture-enriched metagenomic approach enabled the detection of emerging resistance mutations, such as low-frequency variants in &lt;i&gt;ampC&lt;/i&gt; and &lt;i&gt;ftsI&lt;/i&gt;, before these variants rose to fixation. It also revealed genetically res","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0065625"},"PeriodicalIF":3.1,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Planning for the future of the American Society for Microbiology's Health Unit by the Council on Microbial Sciences. 微生物科学理事会对美国微生物学会健康部门的未来进行规划。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-16 DOI: 10.1128/msphere.00633-25
Austin J Fox, Andrea M Prinzi, Nancy W Wamburu, Nicholas M Moore, Michael M Lieberman, Kileen Shier, Nancy L Haigwood

In February and March 2025, the American Society for Microbiology (ASM)'s Council on Microbial Sciences (COMS) hosted a series of virtual retreats to integrate the communities of Clinical Infections and Vaccines (CIV) and Clinical and Public Health Microbiology (CPHM) under the umbrella of the new scientific unit ASM Health. Representatives from these two communities invited experts and ASM members to reflect on the current state of the science, identify challenges hindering scientific advancements, and propose recommendations for overcoming these challenges. Sessions focused on progress in (i) vaccines, therapeutics, diagnostics, and global pathogen surveillance; (ii) improving data integration and cross-agency sharing; (iii) supporting the microbial health workforce; and (iv) gaining public support and confidence in microbiology. Four major recommendations emerged for ASM Health. First, increased support for microbiological science is crucial to ensure the advancement of vaccines, therapeutics, diagnostics, and global pathogen surveillance to mitigate infectious disease threats. Second, enhancement of data integration and sharing in real-time via information systems will facilitate a deeper understanding of disease epidemiology. Third, modern approaches to recruitment, career path, and profession awareness, and dynamic training programs are necessary to achieve microbial workforce balance. Fourth, microbiologists will benefit from outreach training and resources designed to restore public trust in an environment that questions science and evidence-based approaches. ASM is uniquely positioned to take a pivotal leadership role to develop these concepts into specific programs, as well as to enhance partnerships across the spectrum to innovate in funding, both for scientific research and public health.

2025年2月和3月,美国微生物学会(ASM)的微生物科学委员会(COMS)举办了一系列虚拟务静会,将临床感染和疫苗(CIV)和临床和公共卫生微生物学(CPHM)社区整合到新的科学单位ASM Health的保护伞下。来自这两个团体的代表邀请专家和ASM成员反思当前的科学状况,确定阻碍科学进步的挑战,并提出克服这些挑战的建议。会议重点关注以下方面的进展:(i)疫苗、治疗、诊断和全球病原体监测;改进数据整合和跨机构共享;㈢支持微生物保健人员队伍;(四)争取公众对微生物学的支持和信心。ASM Health提出了四项主要建议。首先,增加对微生物科学的支持对于确保疫苗、治疗、诊断和全球病原体监测的进步以减轻传染病威胁至关重要。其次,通过信息系统加强数据整合和实时共享将有助于加深对疾病流行病学的了解。第三,现代化的招聘方式、职业道路、职业意识和动态培训计划是实现微生物劳动力平衡的必要条件。第四,微生物学家将受益于旨在恢复公众对质疑科学和循证方法的环境的信任的外展培训和资源。ASM具有独特的地位,可以发挥关键的领导作用,将这些概念发展为具体的项目,并加强跨领域的伙伴关系,以创新科学研究和公共卫生的资助。
{"title":"Planning for the future of the American Society for Microbiology's Health Unit by the Council on Microbial Sciences.","authors":"Austin J Fox, Andrea M Prinzi, Nancy W Wamburu, Nicholas M Moore, Michael M Lieberman, Kileen Shier, Nancy L Haigwood","doi":"10.1128/msphere.00633-25","DOIUrl":"https://doi.org/10.1128/msphere.00633-25","url":null,"abstract":"<p><p>In February and March 2025, the American Society for Microbiology (ASM)'s Council on Microbial Sciences (COMS) hosted a series of virtual retreats to integrate the communities of Clinical Infections and Vaccines (CIV) and Clinical and Public Health Microbiology (CPHM) under the umbrella of the new scientific unit ASM Health. Representatives from these two communities invited experts and ASM members to reflect on the current state of the science, identify challenges hindering scientific advancements, and propose recommendations for overcoming these challenges. Sessions focused on progress in (i) vaccines, therapeutics, diagnostics, and global pathogen surveillance; (ii) improving data integration and cross-agency sharing; (iii) supporting the microbial health workforce; and (iv) gaining public support and confidence in microbiology. Four major recommendations emerged for ASM Health. First, increased support for microbiological science is crucial to ensure the advancement of vaccines, therapeutics, diagnostics, and global pathogen surveillance to mitigate infectious disease threats. Second, enhancement of data integration and sharing in real-time via information systems will facilitate a deeper understanding of disease epidemiology. Third, modern approaches to recruitment, career path, and profession awareness, and dynamic training programs are necessary to achieve microbial workforce balance. Fourth, microbiologists will benefit from outreach training and resources designed to restore public trust in an environment that questions science and evidence-based approaches. ASM is uniquely positioned to take a pivotal leadership role to develop these concepts into specific programs, as well as to enhance partnerships across the spectrum to innovate in funding, both for scientific research and public health.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0063325"},"PeriodicalIF":3.1,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic analysis of tigecycline-induced colistin collateral sensitivity in carbapenem-resistant Enterobacter cloacae complex. 替加环素诱导的耐碳青霉烯阴沟肠杆菌复合体粘菌素侧枝敏感性的转录组学分析。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-11 DOI: 10.1128/msphere.00903-25
Youtao Liang, Jiming Wu, Jisheng Zhang, Chunli Wei, Jianmin Wang, Wenzhang Long, Xueke Jiang, Yang Yang, Mingjing Liao, Xuemei Gou, Xiaoli Zhang

Utilizing treatment strategies based on collateral sensitivity (CS) represents a promising approach to suppressing antibiotic resistance. Although the mechanism of CS between numerous drugs has been researched, the mechanism of CS between tigecycline and colistin remains unclear. Therefore, the purpose of our research is to investigate the possible mechanism by which tigecycline affects colistin CS in the Enterobacter cloacae complex. Tigecycline induction significantly reduced the minimum inhibitory concentration of carbapenem-resistant Enterobacter cloacae complex (CRECC) to colistin, and sequencing revealed a single-base deletion at the RamR binding site. Complementation experiments demonstrated that deletion of the RamR binding site increased the resistance of CRECC417 to colistin and tigecycline by 2-fold and 4-fold, respectively. Transcriptomic comparison analysis of strains before and after CRECC417 induction revealed a total of 1,977 genes with significant differences in expression. Genes associated with carbohydrate, amino acid, and inorganic ion metabolism were the most highly enriched. Furthermore, the observed increase in colistin susceptibility in CRECC417R can be attributed to the inhibition of quorum sensing and biofilm formation pathways, as well as increased expression levels of genes associated with lipopolysaccharide biosynthesis and modification.IMPORTANCEDue to the overuse of antibiotics, antimicrobial resistance (AMR) has become a serious threat to global public health. Dosage regimens based on bacterial CS can reduce antibiotic use without reducing efficacy, thereby reducing antibiotic-related toxicity risks, expanding the scope of antibiotic application, and limiting the development of antibiotic resistance. In this study, we analyzed the drug resistance mutations and global transcriptional changes in CRECC after tigecycline induction through genomics and transcriptomics. Our study showed that tigecycline exposure significantly inhibited quorum sensing pathways and biofilm formation. There were significant changes in the transcriptional levels of genes related to cell membrane lipopolysaccharide synthesis and modification, but no mutations were found in genes related to colistin resistance. These findings provide valuable insights for further investigation into the CS between tigecycline and colistin.

利用基于侧支敏感性(CS)的治疗策略是抑制抗生素耐药性的一种有希望的方法。虽然已经研究了许多药物之间的CS机制,但替加环素和粘菌素之间的CS机制尚不清楚。因此,我们的研究目的是探讨替加环素影响阴沟肠杆菌复合体中粘菌素CS的可能机制。替加环素诱导显著降低了碳青霉烯耐药阴沟肠杆菌复合体(CRECC)对粘菌素的最低抑制浓度,测序显示RamR结合位点存在单碱基缺失。互补实验表明,缺失RamR结合位点后,CRECC417对粘菌素和替加环素的耐药性分别提高了2倍和4倍。对CRECC417诱导前后菌株的转录组学比较分析显示,共有1,977个基因表达存在显著差异。与碳水化合物、氨基酸和无机离子代谢相关的基因富集程度最高。此外,在CRECC417R中观察到的粘菌素敏感性增加可能归因于群体感应和生物膜形成途径的抑制,以及脂多糖生物合成和修饰相关基因的表达水平增加。由于抗生素的过度使用,抗菌素耐药性(AMR)已成为全球公共卫生的严重威胁。基于细菌CS的给药方案可以在不降低疗效的情况下减少抗生素的使用,从而降低抗生素相关的毒性风险,扩大抗生素的应用范围,限制抗生素耐药性的发展。在本研究中,我们通过基因组学和转录组学分析了替加环素诱导后CRECC的耐药突变和全局转录变化。我们的研究表明,替加环素暴露显著抑制群体感应途径和生物膜的形成。细胞膜脂多糖合成和修饰相关基因的转录水平发生了显著变化,而粘菌素耐药相关基因的转录水平未见突变。这些发现为进一步研究替加环素和粘菌素之间的CS提供了有价值的见解。
{"title":"Transcriptomic analysis of tigecycline-induced colistin collateral sensitivity in carbapenem-resistant <i>Enterobacter cloacae</i> complex.","authors":"Youtao Liang, Jiming Wu, Jisheng Zhang, Chunli Wei, Jianmin Wang, Wenzhang Long, Xueke Jiang, Yang Yang, Mingjing Liao, Xuemei Gou, Xiaoli Zhang","doi":"10.1128/msphere.00903-25","DOIUrl":"https://doi.org/10.1128/msphere.00903-25","url":null,"abstract":"<p><p>Utilizing treatment strategies based on collateral sensitivity (CS) represents a promising approach to suppressing antibiotic resistance. Although the mechanism of CS between numerous drugs has been researched, the mechanism of CS between tigecycline and colistin remains unclear. Therefore, the purpose of our research is to investigate the possible mechanism by which tigecycline affects colistin CS in the <i>Enterobacter cloacae</i> complex. Tigecycline induction significantly reduced the minimum inhibitory concentration of carbapenem-resistant <i>Enterobacter cloacae</i> complex (CRECC) to colistin, and sequencing revealed a single-base deletion at the RamR binding site. Complementation experiments demonstrated that deletion of the RamR binding site increased the resistance of CRECC417 to colistin and tigecycline by 2-fold and 4-fold, respectively. Transcriptomic comparison analysis of strains before and after CRECC417 induction revealed a total of 1,977 genes with significant differences in expression. Genes associated with carbohydrate, amino acid, and inorganic ion metabolism were the most highly enriched. Furthermore, the observed increase in colistin susceptibility in CRECC417R can be attributed to the inhibition of quorum sensing and biofilm formation pathways, as well as increased expression levels of genes associated with lipopolysaccharide biosynthesis and modification.IMPORTANCEDue to the overuse of antibiotics, antimicrobial resistance (AMR) has become a serious threat to global public health. Dosage regimens based on bacterial CS can reduce antibiotic use without reducing efficacy, thereby reducing antibiotic-related toxicity risks, expanding the scope of antibiotic application, and limiting the development of antibiotic resistance. In this study, we analyzed the drug resistance mutations and global transcriptional changes in CRECC after tigecycline induction through genomics and transcriptomics. Our study showed that tigecycline exposure significantly inhibited quorum sensing pathways and biofilm formation. There were significant changes in the transcriptional levels of genes related to cell membrane lipopolysaccharide synthesis and modification, but no mutations were found in genes related to colistin resistance. These findings provide valuable insights for further investigation into the CS between tigecycline and colistin.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0090325"},"PeriodicalIF":3.1,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolutionary dynamics and virulence factor variability in invasive Streptococcus pyogenes in Norway, 2017-2023. 2017-2023年挪威侵袭性化脓性链球菌的进化动态和毒力因子变异。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-11 DOI: 10.1128/msphere.00775-25
Ola Brønstad Brynildsrud, Hilde S Vollan Gjerdrum, Einar Sverre Berg, Astrid L Wester, Dominique A Caugant

Invasive infections caused by Streptococcus pyogenes (iGAS) have increased in Europe over the past decade, with a marked upsurge after the COVID-19 pandemic. Here, we examined whether the increase in iGAS infections in Norway was associated with the spread of variants that had acquired new virulence factors. A collection of 1,163 iGAS isolates submitted to the National Reference Laboratory between January 2017 and April 2023, representing 87% of all cases recorded by the Norwegian Surveillance System for Infectious Diseases, was analyzed by whole genome sequencing. Resistance to one or more antibiotics was found in 15.6% of the isolates: 14.1% were resistant to tetracycline, 6.4% to erythromycin, and 4.0% to clindamycin. Resistance to other antibiotics was < 1%. The dominating emm types were emm1 (30.9%), emm12 (13.8%), emm89 (9.3%), emm28 (8.3%), emm4 (6.0%), and emm87 (4.5%), with the remaining isolates belonging to 55 other emm types; 62.3% of emm1 belonged to the hypervirulent lineage M1UK. Genetic characterization of the virulence factors of the dominant six emm types demonstrated extensive competition between related phages, leading to phage switching and interplay between integration and excision of temperate phages carrying virulence factors. Bacteriophages carrying virulence factors speC and spd1 displayed a particularly high turnover rate, with several pairs of otherwise genomically identical isolates exhibiting different phage-carrying status. We identified and characterized four new speC and spd1-carrying phages. The rapid turnover pattern of these, as well as other phages carrying superantigens and DNAses suggests an important role in pathogenesis.IMPORTANCEThis analysis of 1,163 iGAS isolates collected between January 2017 and April 2023 aimed to map virulence factor content to understand the observed increased incidence of iGAS in Norway. Our findings indicate that 15.6% of the isolates were resistant to at least one antibiotic, with tetracycline resistance being the most common. The dominant emm types were emm1, emm4, emm12, emm28, emm87, and emm89, which together accounted for 72.7% of the isolates. The study highlights the dynamic nature of virulence factor-carrying temperate phages, particularly the ones carrying speC and spd1, which frequently integrate and excise within emm types. Four previously unseen phages carrying speC and spd1 were identified and characterized. This research underscores the complexity of iGAS epidemiology and the need for continuous surveillance to understand the evolving landscape of bacterial virulence factors, antibiotic resistance, and circulating emm types.

在过去十年中,由化脓性链球菌(iGAS)引起的侵袭性感染在欧洲有所增加,在2019冠状病毒病大流行后显著增加。在这里,我们研究了挪威iGAS感染的增加是否与获得新毒力因子的变异传播有关。通过全基因组测序分析了2017年1月至2023年4月期间提交给国家参考实验室的1163株iGAS分离株,占挪威传染病监测系统记录的所有病例的87%。15.6%的菌株对一种或多种抗生素耐药,其中对四环素耐药14.1%,对红霉素耐药6.4%,对克林霉素耐药4.0%。对其他抗生素耐药< 1%。主要菌株为emm1型(30.9%)、emm12型(13.8%)、emm89型(9.3%)、emm28型(8.3%)、emm4型(6.0%)和emm87型(4.5%),其余菌株属于55种其他类型;62.3%的emm1属于高毒力系M1UK。六种主要emm类型的毒力因子的遗传特征表明,相关噬菌体之间存在广泛的竞争,导致噬菌体切换以及携带毒力因子的温带噬菌体的整合和切除之间的相互作用。携带毒力因子speC和spd1的噬菌体表现出特别高的周转率,几对基因组完全相同的分离株表现出不同的噬菌体携带状态。我们鉴定并鉴定了4个新的携带speC和spd1的噬菌体。这些噬菌体以及其他携带超抗原和dna酶的噬菌体的快速周转模式表明在发病机制中起重要作用。对2017年1月至2023年4月期间收集的1163株iGAS分离株进行分析,旨在绘制毒力因子含量图,以了解挪威观察到的iGAS发病率增加情况。我们的研究结果表明,15.6%的分离株至少对一种抗生素耐药,其中四环素耐药最为常见。优势型为emm1、emm4、emm12、emm28、emm87和emm89,共占72.7%。该研究强调了携带毒力因子的温带噬菌体的动态性质,特别是携带speC和spd1的噬菌体,它们经常在emm类型中整合和剔除。鉴定和表征了四个先前未见过的携带speC和spd1的噬菌体。这项研究强调了iGAS流行病学的复杂性和持续监测的必要性,以了解细菌毒力因子、抗生素耐药性和循环emm类型的演变情况。
{"title":"Evolutionary dynamics and virulence factor variability in invasive <i>Streptococcus pyogenes</i> in Norway, 2017-2023.","authors":"Ola Brønstad Brynildsrud, Hilde S Vollan Gjerdrum, Einar Sverre Berg, Astrid L Wester, Dominique A Caugant","doi":"10.1128/msphere.00775-25","DOIUrl":"https://doi.org/10.1128/msphere.00775-25","url":null,"abstract":"<p><p>Invasive infections caused by <i>Streptococcus pyogenes</i> (iGAS) have increased in Europe over the past decade, with a marked upsurge after the COVID-19 pandemic. Here, we examined whether the increase in iGAS infections in Norway was associated with the spread of variants that had acquired new virulence factors. A collection of 1,163 iGAS isolates submitted to the National Reference Laboratory between January 2017 and April 2023, representing 87% of all cases recorded by the Norwegian Surveillance System for Infectious Diseases, was analyzed by whole genome sequencing. Resistance to one or more antibiotics was found in 15.6% of the isolates: 14.1% were resistant to tetracycline, 6.4% to erythromycin, and 4.0% to clindamycin. Resistance to other antibiotics was < 1%. The dominating <i>emm</i> types were <i>emm1</i> (30.9%), <i>emm12</i> (13.8%), <i>emm89</i> (9.3%), <i>emm28</i> (8.3%), <i>emm4</i> (6.0%), and <i>emm87</i> (4.5%), with the remaining isolates belonging to 55 other <i>emm</i> types; 62.3% of <i>emm1</i> belonged to the hypervirulent lineage M1<sub>UK</sub>. Genetic characterization of the virulence factors of the dominant six <i>emm</i> types demonstrated extensive competition between related phages, leading to phage switching and interplay between integration and excision of temperate phages carrying virulence factors. Bacteriophages carrying virulence factors <i>speC</i> and <i>spd1</i> displayed a particularly high turnover rate, with several pairs of otherwise genomically identical isolates exhibiting different phage-carrying status. We identified and characterized four new <i>speC</i> and <i>spd1</i>-carrying phages. The rapid turnover pattern of these, as well as other phages carrying superantigens and DNAses suggests an important role in pathogenesis.IMPORTANCEThis analysis of 1,163 iGAS isolates collected between January 2017 and April 2023 aimed to map virulence factor content to understand the observed increased incidence of iGAS in Norway. Our findings indicate that 15.6% of the isolates were resistant to at least one antibiotic, with tetracycline resistance being the most common. The dominant <i>emm</i> types were <i>emm</i>1, <i>emm</i>4, <i>emm</i>12, <i>emm</i>28, <i>emm</i>87, and <i>emm</i>89, which together accounted for 72.7% of the isolates. The study highlights the dynamic nature of virulence factor-carrying temperate phages, particularly the ones carrying <i>speC</i> and <i>spd1</i>, which frequently integrate and excise within <i>emm</i> types. Four previously unseen phages carrying <i>speC</i> and <i>spd1</i> were identified and characterized. This research underscores the complexity of iGAS epidemiology and the need for continuous surveillance to understand the evolving landscape of bacterial virulence factors, antibiotic resistance, and circulating <i>emm</i> types.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0077525"},"PeriodicalIF":3.1,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
mSphere of Influence: The power of in situ-structural biology without leaving "home". 影响范围:在不离开“家”的情况下结构生物学的力量。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-09 DOI: 10.1128/msphere.00798-25
Nicholas A Wood

Nicholas A. Wood works in the field of biophysics with an emphasis on in situ protein structures in microbiological systems. In this mSphere of Influence article, he reflects on the power and limitations of AlphaFold, open questions in structural biology, and the cross-disciplinary potential of microbiological training.

尼古拉斯A.伍德在生物物理学领域工作,重点是微生物系统中的原位蛋白质结构。在这篇影响氛围的文章中,他反思了AlphaFold的力量和局限性,结构生物学中的开放性问题,以及微生物训练的跨学科潜力。
{"title":"mSphere of Influence: The power of <i>in situ</i>-structural biology without leaving \"home\".","authors":"Nicholas A Wood","doi":"10.1128/msphere.00798-25","DOIUrl":"https://doi.org/10.1128/msphere.00798-25","url":null,"abstract":"<p><p>Nicholas A. Wood works in the field of biophysics with an emphasis on <i>in situ</i> protein structures in microbiological systems. In this mSphere of Influence article, he reflects on the power and limitations of AlphaFold, open questions in structural biology, and the cross-disciplinary potential of microbiological training.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0079825"},"PeriodicalIF":3.1,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147377359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
mSphere of Influence: Rethinking microbial identity through variability. 影响范围:通过可变性重新思考微生物的同一性。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-09 DOI: 10.1128/msphere.00026-26
Laura Veschetti

Laura Veschetti works in the field of microbial genomics and adaptation. In this mSphere of Influence article, she reflects on how the work of Marvig et al. on within-host evolution of Pseudomonas aeruginosa, together with long-term evolution experiments by Lenski and colleagues, reshaped her understanding of microbial identity by framing variability as a defining biological feature rather than an exception. Drawing on concepts from population genomics, pangenomics, and regulatory heterogeneity, she discusses how focusing on evolutionary processes rather than static reference genomes has influenced her approach to studying bacterial adaptation.

Laura Veschetti在微生物基因组学和适应领域工作。在这篇mSphere of Influence文章中,她回顾了Marvig等人关于铜绿假单胞菌宿主内进化的研究,以及Lenski及其同事的长期进化实验,通过将变异视为一种决定性的生物学特征而非例外,重塑了她对微生物身份的理解。利用种群基因组学、泛基因组学和调控异质性的概念,她讨论了关注进化过程而不是静态参考基因组如何影响了她研究细菌适应的方法。
{"title":"mSphere of Influence: Rethinking microbial identity through variability.","authors":"Laura Veschetti","doi":"10.1128/msphere.00026-26","DOIUrl":"https://doi.org/10.1128/msphere.00026-26","url":null,"abstract":"<p><p>Laura Veschetti works in the field of microbial genomics and adaptation. In this mSphere of Influence article, she reflects on how the work of Marvig et al. on within-host evolution of <i>Pseudomonas aeruginosa</i>, together with long-term evolution experiments by Lenski and colleagues, reshaped her understanding of microbial identity by framing variability as a defining biological feature rather than an exception. Drawing on concepts from population genomics, pangenomics, and regulatory heterogeneity, she discusses how focusing on evolutionary processes rather than static reference genomes has influenced her approach to studying bacterial adaptation.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0002626"},"PeriodicalIF":3.1,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights into bacterial stress adaptation, host interactions, and drug resistance: key findings from the fall 2025 ASM Theobald Smith Society meeting. 洞察细菌应激适应,宿主相互作用和耐药性:从秋季2025年ASM西奥博尔德·史密斯学会会议的主要发现。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-06 DOI: 10.1128/msphere.00878-25
Nitish Sharma, Madhulika Singh, Joycelyn Radeny, Arpita Mukherjee, Raymond F Sullivan, Jeffrey M Boyd, Valerie J Carabetta, Jason H Yang, Srujana S Yadavalli

The annual fall meeting for the Theobald Smith Society (TSS), the New Jersey Branch of the American Society for Microbiology (ASM), took place in November 2025 at Cooper Medical School of Rowan University in Camden, New Jersey. A total of 72 branch members from across New Jersey participated, including undergraduate and graduate students, postdoctoral trainees, faculty, and professionals from government and industry. This report highlights the scope and diversity of research carried out by TSS members and celebrates their impactful discoveries.

美国微生物学会(ASM)新泽西分会西奥博尔德·史密斯学会(TSS)的年度秋季会议于2025年11月在新泽西州卡姆登的罗文大学库珀医学院举行。来自新泽西州各地的72名分会成员参加了会议,其中包括本科生和研究生、博士后学员、教师以及来自政府和行业的专业人士。本报告强调了TSS成员开展的研究的范围和多样性,并庆祝他们有影响力的发现。
{"title":"Insights into bacterial stress adaptation, host interactions, and drug resistance: key findings from the fall 2025 ASM Theobald Smith Society meeting.","authors":"Nitish Sharma, Madhulika Singh, Joycelyn Radeny, Arpita Mukherjee, Raymond F Sullivan, Jeffrey M Boyd, Valerie J Carabetta, Jason H Yang, Srujana S Yadavalli","doi":"10.1128/msphere.00878-25","DOIUrl":"https://doi.org/10.1128/msphere.00878-25","url":null,"abstract":"<p><p>The annual fall meeting for the Theobald Smith Society (TSS), the New Jersey Branch of the American Society for Microbiology (ASM), took place in November 2025 at Cooper Medical School of Rowan University in Camden, New Jersey. A total of 72 branch members from across New Jersey participated, including undergraduate and graduate students, postdoctoral trainees, faculty, and professionals from government and industry. This report highlights the scope and diversity of research carried out by TSS members and celebrates their impactful discoveries.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0087825"},"PeriodicalIF":3.1,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147365887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential assembly and functional roles of bacterial communities in coniferous and mixed conifer-broadleaf forest soils. 针叶林和针叶林-阔叶林混交林土壤细菌群落的差异组合及其功能作用。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-03-06 DOI: 10.1128/msphere.00627-25
Dexing Chen, Ziyang Zhang, Shunfen Wang, Wenhui Li, Yimin He, Wenyu Zhang, Weiwei Sun, Mingjiu Chen, Shuangquan Zou, Xin Qian

Forest soils harbor a diverse array of bacteria that play a crucial role in nutrient cycling. However, the differential effects of coniferous versus mixed conifer-broadleaf forests on the distribution of both abundant and rare bacterial taxa remain poorly understood. In this study, we integrated 16S rRNA gene amplicon sequencing with metagenomic shotgun sequencing to conduct a comparative analysis of soil bacterial communities in a conifer plantation and an adjacent mixed conifer-broadleaf forest, specifically examining their community structure, assembly mechanisms, co-occurrence networks, and functional potential. Both abundant and rare taxa showed significant differences in community composition between the two forest types. Soil pH and organic matter content significantly influenced the total and abundant bacterial communities, while available phosphorus and potassium were key determinants of rare community composition. Co-occurrence network analysis revealed that abundant communities formed highly clustered, simplified networks, contrasting with more fragmented and keystone-rich networks in rare communities. Null model analyses indicated that community assembly was largely driven by stochastic processes, with ecological drift accounting for about 80% of the variation in total and rare communities, and dispersal limitation explaining nearly 72% of the variation in abundant communities. Functional predictions indicated that bacterial communities in mixed forests were enriched in pathways linked to glycosylation, carbohydrate degradation, and nitrogen fixation, while coniferous forests favored pathways related to autophagy, signaling, and stress responses. This study highlights the complementary roles of abundant and rare bacterial taxa in forest soil ecosystems and underscores the importance of preserving mixed forests to sustain microbial functional diversity.IMPORTANCEForest soils host a complex web of common and rare bacteria that quietly regulate nutrient cycles. By comparing pure conifer stands with mixed conifer-broadleaf forests, we found that abundant species underpin essential functions while rarer microbes fill specialized niches. Acidity and nutrients strongly influence which bacteria thrive; mixed stands favored microbes that break down carbohydrates and fix nitrogen, whereas conifer soils supported organisms adapted to stress and nutrient-poor conditions. These findings emphasize the importance of preserving diverse forest ecosystems for soil health, carbon storage, and effective forest management strategies in climate change adaptation.

森林土壤中有各种各样的细菌,它们在养分循环中起着至关重要的作用。然而,针叶林与针叶林混交林对丰富和稀有细菌分类群分布的差异影响仍然知之甚少。本研究将16S rRNA基因扩增子测序与宏基因组霰弹枪测序相结合,对针叶林和邻近针叶林土壤细菌群落进行了比较分析,重点研究了它们的群落结构、组装机制、共生网络和功能潜力。两种林型的丰富和稀有类群在群落组成上均存在显著差异。土壤pH和有机质含量显著影响细菌群落总数和丰富度,速效磷和速效钾是稀有群落组成的关键决定因素。共现网络分析表明,数量较多的群落形成了高度集群化、简化的网络,而数量较少的群落形成了碎片化、富含关键节点的网络。零模型分析表明,群落聚集主要受随机过程驱动,生态漂变占总群落和稀有群落变异的80%左右,分散限制解释了丰富群落变异的近72%。功能预测表明,混交林中的细菌群落富含与糖基化、碳水化合物降解和固氮相关的途径,而针叶林则倾向于自噬、信号传导和应激反应相关的途径。本研究强调了丰富和罕见的细菌类群在森林土壤生态系统中的互补作用,并强调了保护混交林对维持微生物功能多样性的重要性。森林土壤承载着一个由常见和稀有细菌组成的复杂网络,它们悄无声息地调节着养分循环。通过比较纯针叶林与针叶林混交林,我们发现丰富的物种支撑着基本功能,而罕见的微生物填补了特定的生态位。酸度和营养物质强烈影响细菌的繁殖;混合林分有利于分解碳水化合物和固定氮的微生物,而针叶林土壤则支持适应压力和营养不良条件的微生物。这些发现强调了保护多样化森林生态系统对土壤健康、碳储存和有效的森林管理战略在气候变化适应中的重要性。
{"title":"Differential assembly and functional roles of bacterial communities in coniferous and mixed conifer-broadleaf forest soils.","authors":"Dexing Chen, Ziyang Zhang, Shunfen Wang, Wenhui Li, Yimin He, Wenyu Zhang, Weiwei Sun, Mingjiu Chen, Shuangquan Zou, Xin Qian","doi":"10.1128/msphere.00627-25","DOIUrl":"https://doi.org/10.1128/msphere.00627-25","url":null,"abstract":"<p><p>Forest soils harbor a diverse array of bacteria that play a crucial role in nutrient cycling. However, the differential effects of coniferous versus mixed conifer-broadleaf forests on the distribution of both abundant and rare bacterial taxa remain poorly understood. In this study, we integrated 16S rRNA gene amplicon sequencing with metagenomic shotgun sequencing to conduct a comparative analysis of soil bacterial communities in a conifer plantation and an adjacent mixed conifer-broadleaf forest, specifically examining their community structure, assembly mechanisms, co-occurrence networks, and functional potential. Both abundant and rare taxa showed significant differences in community composition between the two forest types. Soil pH and organic matter content significantly influenced the total and abundant bacterial communities, while available phosphorus and potassium were key determinants of rare community composition. Co-occurrence network analysis revealed that abundant communities formed highly clustered, simplified networks, contrasting with more fragmented and keystone-rich networks in rare communities. Null model analyses indicated that community assembly was largely driven by stochastic processes, with ecological drift accounting for about 80% of the variation in total and rare communities, and dispersal limitation explaining nearly 72% of the variation in abundant communities. Functional predictions indicated that bacterial communities in mixed forests were enriched in pathways linked to glycosylation, carbohydrate degradation, and nitrogen fixation, while coniferous forests favored pathways related to autophagy, signaling, and stress responses. This study highlights the complementary roles of abundant and rare bacterial taxa in forest soil ecosystems and underscores the importance of preserving mixed forests to sustain microbial functional diversity.IMPORTANCEForest soils host a complex web of common and rare bacteria that quietly regulate nutrient cycles. By comparing pure conifer stands with mixed conifer-broadleaf forests, we found that abundant species underpin essential functions while rarer microbes fill specialized niches. Acidity and nutrients strongly influence which bacteria thrive; mixed stands favored microbes that break down carbohydrates and fix nitrogen, whereas conifer soils supported organisms adapted to stress and nutrient-poor conditions. These findings emphasize the importance of preserving diverse forest ecosystems for soil health, carbon storage, and effective forest management strategies in climate change adaptation.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0062725"},"PeriodicalIF":3.1,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147365964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durable protection against lethal Rift Valley fever hepatitis and encephalitis following low-dose ΔNSsΔNSm vaccination in mice. 小鼠低剂量ΔNSsΔNSm疫苗对致命性裂谷热、肝炎和脑炎的持久保护作用。
IF 3.1 2区 生物学 Q2 MICROBIOLOGY Pub Date : 2026-02-27 DOI: 10.1128/msphere.00894-25
Karina Mueller Brown, Angel M Kindsvogel, Lingqing Xu, Ashley M Divens, Anita K McElroy

Rift Valley fever virus (RVFV) is a zoonotic arbovirus that infects and causes disease in both humans and livestock. In humans, RVFV infection mostly results in febrile illness but has the potential to cause severe complications such as hepatitis and encephalitis. There are currently no licensed vaccines for human use; however, several candidates have been shown to be safe and immunogenic in pre-clinical studies. However, there remain gaps in our knowledge, including the duration of immunity and efficacy of protection from divergent disease manifestations over time. This pilot study investigated the duration of immunity following low-dose vaccination with live-attenuated RVFV ΔNSsΔNSm in two murine models with divergent RVF disease manifestations. Following percutaneous infection with wild-type (WT) RVFV, C57BL/6 mice readily succumb to fulminant hepatitis 3 to 5 days post-infection (dpi). In contrast, CC057/Unc mice from the Collaborative Cross Resource experience self-limiting liver disease and develop late-onset encephalitis. Following ΔNSsΔNSm vaccination, both humoral and cellular immunity decreased over time but were comparable between the two mouse strains at 1 and 3 months. Vaccinated mice were challenged with WT RVFV (ZH501) 6 months later, and 83% of C57BL/6 mice and 100% of CC057/Unc mice survived. Taken together, this study highlights the potential of ΔNSsΔNSm to provide durable protection against lethal RVF hepatitis and encephalitis.IMPORTANCERift Valley fever virus (RVFV) causes both morbidity and mortality in endemic areas of Africa and the Middle East; however, no vaccines are available for humans. Pre-clinical studies have investigated the safety and immunogenicity of ΔNSsΔNSm vaccine (a live-attenuated version of RVFV that has two virulence factors deleted), but the duration of immunity and protection in the context of divergent RVF disease manifestations was unknown. This pilot study demonstrated that a single, low dose of ΔNSsΔNSm provided substantial protection to mice from RVF hepatitis and encephalitis 6 months post-vaccination. These pre-clinical data could support further development of a live-attenuated vaccine based on this platform for human use.

裂谷热病毒(RVFV)是一种人畜共患虫媒病毒,可在人类和牲畜中感染并引起疾病。在人类中,裂谷热病毒感染主要导致发热性疾病,但也有可能导致严重并发症,如肝炎和脑炎。目前还没有获得许可的人用疫苗;然而,在临床前研究中,一些候选药物已被证明是安全和免疫原性的。然而,我们的知识仍然存在差距,包括免疫的持续时间和随着时间的推移对不同疾病表现的保护效力。这项初步研究调查了在两种具有不同裂谷热病表现的小鼠模型中低剂量接种减毒裂谷热病毒ΔNSsΔNSm后的免疫持续时间。经皮感染野生型(WT) RVFV后,C57BL/6小鼠在感染后3至5天容易死于暴发性肝炎(dpi)。相比之下,来自协作交叉资源的CC057/Unc小鼠会出现自限性肝病并发展为晚发性脑炎。接种ΔNSsΔNSm疫苗后,体液和细胞免疫均随时间下降,但在1个月和3个月时两种小鼠品系之间具有可比性。6个月后用WT RVFV (ZH501)攻毒,C57BL/6小鼠的存活率为83%,CC057/Unc小鼠的存活率为100%。综上所述,这项研究突出了ΔNSsΔNSm在提供针对致命裂谷热肝炎和脑炎的持久保护方面的潜力。重要性裂谷热病毒(RVFV)在非洲和中东流行地区造成发病率和死亡率;然而,目前还没有人类可用的疫苗。临床前研究已经调查了ΔNSsΔNSm疫苗(一种去除了两个毒力因子的裂谷热病毒减毒活疫苗)的安全性和免疫原性,但在裂谷热病不同表现的情况下,免疫和保护的持续时间尚不清楚。这项初步研究表明,单次低剂量ΔNSsΔNSm在接种疫苗6个月后对小鼠提供了大量保护,使其免受裂谷热肝炎和脑炎的侵害。这些临床前数据可支持进一步开发基于该平台的人用减毒活疫苗。
{"title":"Durable protection against lethal Rift Valley fever hepatitis and encephalitis following low-dose ΔNSsΔNSm vaccination in mice.","authors":"Karina Mueller Brown, Angel M Kindsvogel, Lingqing Xu, Ashley M Divens, Anita K McElroy","doi":"10.1128/msphere.00894-25","DOIUrl":"10.1128/msphere.00894-25","url":null,"abstract":"<p><p>Rift Valley fever virus (RVFV) is a zoonotic arbovirus that infects and causes disease in both humans and livestock. In humans, RVFV infection mostly results in febrile illness but has the potential to cause severe complications such as hepatitis and encephalitis. There are currently no licensed vaccines for human use; however, several candidates have been shown to be safe and immunogenic in pre-clinical studies. However, there remain gaps in our knowledge, including the duration of immunity and efficacy of protection from divergent disease manifestations over time. This pilot study investigated the duration of immunity following low-dose vaccination with live-attenuated RVFV ΔNSsΔNSm in two murine models with divergent RVF disease manifestations. Following percutaneous infection with wild-type (WT) RVFV, C57BL/6 mice readily succumb to fulminant hepatitis 3 to 5 days post-infection (dpi). In contrast, CC057/Unc mice from the Collaborative Cross Resource experience self-limiting liver disease and develop late-onset encephalitis. Following ΔNSsΔNSm vaccination, both humoral and cellular immunity decreased over time but were comparable between the two mouse strains at 1 and 3 months. Vaccinated mice were challenged with WT RVFV (ZH501) 6 months later, and 83% of C57BL/6 mice and 100% of CC057/Unc mice survived. Taken together, this study highlights the potential of ΔNSsΔNSm to provide durable protection against lethal RVF hepatitis and encephalitis.IMPORTANCERift Valley fever virus (RVFV) causes both morbidity and mortality in endemic areas of Africa and the Middle East; however, no vaccines are available for humans. Pre-clinical studies have investigated the safety and immunogenicity of ΔNSsΔNSm vaccine (a live-attenuated version of RVFV that has two virulence factors deleted), but the duration of immunity and protection in the context of divergent RVF disease manifestations was unknown. This pilot study demonstrated that a single, low dose of ΔNSsΔNSm provided substantial protection to mice from RVF hepatitis and encephalitis 6 months post-vaccination. These pre-clinical data could support further development of a live-attenuated vaccine based on this platform for human use.</p>","PeriodicalId":19052,"journal":{"name":"mSphere","volume":" ","pages":"e0089425"},"PeriodicalIF":3.1,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147308149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
mSphere
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1